Claritin 24hr Non-Drowsy Allergy Relief, Loratadine Tablets – 100ct
Original price was: $49.99.$44.97Current price is: $44.97.
Price: $49.99 - $44.97
(as of Jun 18, 2024 18:22:04 UTC – Details)
Claritin tablets provide powerful, 24-hour, non-drowsy relief of your worst indoor and outdoor allergy symptoms, including sneezing, runny nose, itchy/watery eyes and itchy throat/nose. Claritin provides relief of symptoms that can be triggered by over 200 different allergens. Claritin is an antihistamine, so it hinders the cascade triggered by allergens. For adults and children ages 6+. One tablet contains 10 mg of loratadine. Covered by the Bayer HealthCare – Consumer Health 60-Day Satisfaction Guarantee.
Is Discontinued By Manufacturer : No
Product Dimensions : 3.76 x 1.55 x 3.08 inches; 0.01 ounces
Item model number : B078BBYNLC
Date First Available : February 26, 2018
Manufacturer : Bayer HealthCare LLC
ASIN : B078BBYNLC
Country of Origin : Ireland
This Claritin pack contains 100 days of non drowsy allergy relief.
Powerful, 24 hour, non drowsy indoor and outdoor allergy relief
#1 doctor recommended non-drowsy oral allergy brand. *
No prescription needed: Find relief of allergy symptoms triggered by over 200 different allergens from pets, pollen, dust and mold.
Relief of your worst allergy symptoms including sneezing, runny nose, itchy/watery eyes and itchy throat/nose
Claritin contains 10 milligrams of loratadine per tablet, that blocks the effects of histamines in the body.
HSA/FSA Eligible — Check your plan for coverage.
Customers say
Customers like the value, ease of swallowing, performance, effect on nasal congestion, and skin. They mention that it works great for all their symptoms, it stops their running nose, and that it helps with allergies. Customers also appreciate sleep quality.
AI-generated from the text of customer reviews
User Reviews
Be the first to review “Claritin 24hr Non-Drowsy Allergy Relief, Loratadine Tablets – 100ct”
Original price was: $49.99.$44.97Current price is: $44.97.
There are no reviews yet.